- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ibrutinib and novel BTK inhibitors in clinical development ; volume:6 ; number:1 ; day:19 ; month:8 ; year:2013 ; pages:1-9 ; date:12.2013
Journal of hematology & oncology ; 6, Heft 1 (19.8.2013), 1-9, 12.2013
- Creator
-
Akinleye, Akintunde
Chen, Yamei
Mukhi, Nikhil
Song, Yongping
Liu, Delong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-8722-6-59
- URN
-
urn:nbn:de:101:1-2021081722133319046268
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Akinleye, Akintunde
- Chen, Yamei
- Mukhi, Nikhil
- Song, Yongping
- Liu, Delong
- SpringerLink (Online service)
Other Objects (12)
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation
Integrin signaling shaping BTK-inhibitor resistance
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Novel mutations associated with resistance to BTK inhibitors and alternative treatment strategies
BTK
BTK
BTK
BTK
BTK
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation
Integrin signaling shaping BTK-inhibitor resistance
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Novel mutations associated with resistance to BTK inhibitors and alternative treatment strategies
BTK
BTK
BTK
BTK
BTK
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation
Integrin signaling shaping BTK-inhibitor resistance
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Novel mutations associated with resistance to BTK inhibitors and alternative treatment strategies
BTK
BTK
BTK
BTK